Martino E, Aghini-Lombardi F, Lippi F, Baschieri L, Safran M, Braverman L E, Pinchera A
J Nucl Med. 1985 Dec;26(12):1402-7.
Amiodarone associated thyrotoxicosis (AAT) occurs in approximately 10% of patients treated with this iodine rich drug in areas of mild iodine deficiency. The thyroid radioactive iodine uptake (RAIU) is usually undetectable or very low in iodine-induced thyrotoxicosis. In the present study, 35 patients with AAT were evaluated. Twelve patients had no thyroid abnormalities by physical exam and all had 24-hr RAIU less than or equal to 4%. In contrast, nine of 11 patients with AAT and diffuse goiters and eight of 12 patients with AAT and nodular goiters had RAIU values greater than 8%. In patients with AAT and goiter it appears possible that the thyroid fails to adapt normally to the excess iodide load, resulting in an inappropriately high RAIU in the presence of excess plasma iodine.
胺碘酮相关性甲状腺毒症(AAT)在轻度碘缺乏地区接受这种富碘药物治疗的患者中发生率约为10%。在碘致甲状腺毒症中,甲状腺放射性碘摄取(RAIU)通常检测不到或非常低。在本研究中,对35例AAT患者进行了评估。12例患者体格检查未发现甲状腺异常,且所有患者的24小时RAIU均小于或等于4%。相比之下,11例AAT合并弥漫性甲状腺肿患者中有9例以及12例AAT合并结节性甲状腺肿患者中有8例的RAIU值大于8%。在AAT合并甲状腺肿的患者中,甲状腺似乎无法正常适应过量的碘负荷,导致在血浆碘过量的情况下RAIU异常升高。